Acute Adverse Reactions to Gadolinium-Based Contrast Agents in CMR: Multicenter Experience With 17,767 Patients From the EuroCMR Registry

Study Questions:

What is the frequency, nature, and severity of acute adverse reactions following the administration of gadolinium-based contrast agents (GBCAs) to patients undergoing cardiac magnetic resonance imaging (CMR)?